Publication:
Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity

dc.contributor.authorsKalaca, S; Yalcin, M; Yavuz, SS
dc.date.accessioned2022-03-12T17:17:32Z
dc.date.accessioned2026-01-11T18:21:29Z
dc.date.available2022-03-12T17:17:32Z
dc.date.issued2004
dc.description.abstractThe aim of this study was to identify the seroprevalance rate of tetanus and to determine missed opportunities for tetanus vaccination. Two hundred and twenty-seven female volunteers who were hospitalized following delivery participated in the study. Blood samples were analyzed using enzyme-linked immunoassay to measure tetanus antibody levels. In addition, a questionnaire was used to investigate the factors associated with vaccination status. Sixty-five percent of the study participants had safe protective levels of antibodies. Factors associated with antibody level were age, level of education and number of doses. Only 25.7% of women who received antenatal care (ANC) had received tetanus vaccinations. Women who received ANC from primary healthcare facilities were more likely to have been vaccinated than those who received ANC from hospitals or private practice (P < 0.05). Factors associated with both tetanus vaccination and immunizations in pregnant women should be further investigated by qualitative and quantitative studies. Knowledge, attitude and practice surveys of mothers and healthcare providers on provision of the tetanus vaccine to pregnant women need to be undertaken urgently. (C) 2004 The Royal Institute of Public Health. Published by Elsevier Ltd. All rights reserved.
dc.identifier.doi10.1016/j.puhe.2003.12.011
dc.identifier.eissn1476-5616
dc.identifier.issn0033-3506
dc.identifier.pubmed15178146
dc.identifier.urihttps://hdl.handle.net/11424/227861
dc.identifier.wosWOS:000221988200011
dc.language.isoeng
dc.publisherW B SAUNDERS CO LTD
dc.relation.ispartofPUBLIC HEALTH
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectneonatal tetanus
dc.subjectmissed opportunities for vaccination
dc.subjecttetanus seroprevalance
dc.subjectmaternal health
dc.subjectIMMUNIZATION
dc.subjectANTIBODY
dc.subjectTURKEY
dc.titleMissed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage382
oaire.citation.issue5
oaire.citation.startPage377
oaire.citation.titlePUBLIC HEALTH
oaire.citation.volume118

Files